-, -, ERYTHROPOIETIN , DANAZOL , VAY736, -, ENTECAVIR , Placebo to VAY736 150 mg/1 mL concentrate for solution for infusion, -, -
CVAY736O12301
Phase 3 small_molecule active
Quick answer
-, -, ERYTHROPOIETIN , DANAZOL , VAY736, -, ENTECAVIR , Placebo to VAY736 150 mg/1 mL concentrate for solution for infusion, -, - for warm autoimmune haemolytic anaemia (wAIHA) is a Phase 3 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- warm autoimmune haemolytic anaemia (wAIHA)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active